Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ANKRD30B
REST API REST API
Homo sapiens
ANKRD30B is differentially expressed in 66 experiments: 32 organism parts: mammary gland, prostate, ... (30 more);, 24 disease states: prostate carcinoma, Bmi1-shRNA, ... (22 more);, 17 cell types 16 cell lines 5 compound treatments and 30 other conditions.
Synonyms NY-BR-1.1
Orthologs ANKRD30B (Danio rerio)   ENSCING00000017049 (Ciona intestinalis)   ENSCING00000012242 (Ciona intestinalis)   ccdc144a (Xenopus laevis)   (Compare orthologs)
InterPro Term Ankyrin_rpt, Ankyrin_rpt-contain_dom
Gene Ontology Term protein binding
UniProt Accession Q9BXX2, F8WAG3
Search EB-eye ENSG00000180777
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-7307, E-GEOD-15460, E-GEOD-3526, E-GEOD-20081 ... (5 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-MEXP-2034, E-GEOD-20089, E-GEOD-19639, E-GEOD-6013, ... (9 experiments)

Factor Value U/D Experiments
CWR22Rv1
1
E-GEOD-17482
U-937
1
E-GEOD-24147
primary cell
1
E-MEXP-2034
Beas2B
1
E-GEOD-6013
MCF-7
2
1
E-GEOD-20081
ZR75-1
1
E-GEOD-19639
10 more value(s).


Cell type

studied in E-GEOD-15893, E-AFMX-5, E-GEOD-18811, E-MEXP-2360, E-GEOD-11755, ... (8 experiments)

Factor Value U/D Experiments
CD56+ NK cells
1
1
E-AFMX-5
CD8+ T cell
2
1
E-AFMX-5
adipocyte
1
1
E-AFMX-5
testis - germ cell
1
E-AFMX-5
plasma cell
1
E-MEXP-2360
CXCR4 positive
1
E-GEOD-15893
11 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-AFMX-5, E-GEOD-21912, E-GEOD-8514, ... (14 experiments)

Factor Value U/D Experiments
prostate carcinoma
2
E-MEXP-2034, E-GEOD-7307
asymptomatic HIV-1 infection
1
E-GEOD-16363
gastric carcinoma
1
E-GEOD-15460
reference
1
E-GEOD-8514
monoclonal gammopathy of uncertain significance
1
E-MTAB-372
Raji Burkitt's lymphoma
1
1
E-AFMX-5
18 more value(s).


Compound treatment

studied in E-GEOD-5741, E-GEOD-7307, E-GEOD-20081

Factor Value U/D Experiments
Cxcl12
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
ox-LDL
1
E-GEOD-5741
unknown
1
E-GEOD-7307
not specified
1
E-GEOD-20081


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-16363, E-GEOD-19293

Clinical treatment
studied in E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21887

Environmental stress
studied in E-GEOD-1643

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-20847, E-MEXP-563

Genotype
studied in E-GEOD-22056, E-MEXP-421, E-TABM-601

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-9764, E-GEOD-10315

Histology
studied in E-TABM-234

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-1243, E-TABM-666, E-GEOD-19519, ... (10 experiments)

Infection
studied in E-MEXP-561

Injury
studied in E-GEOD-19743

Material type
studied in E-GEOD-9171

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-TABM-84

P53 ihc
studied in E-GEOD-21653

Protocol type
studied in E-GEOD-19246

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-1857

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Stimulation
studied in E-GEOD-11428

Treatment
studied in E-GEOD-19246

Processing time: 0.511 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM